America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Choosing between SP 500 and multi-asset strategies depends on goals and risk comfort. This intro contrasts outcomes to guide retirement design.
26,826 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
A high-profile Pentagon briefing in Brussels on a NATO trip sparks a six-month review of American forces in Europe. M...
A narrow, theme-driven ETF focused on generative AI shows mixed results as broader AI funds rally. The concentrated a...
YieldMax’s ULTY ETF has paid out consistently high weekly distributions, yet two-year data show a stark mismatch betw...
Investors await the July 14 CPI release to gauge the path of inflation and interest rates. This guide breaks down wha...
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
The era of persistently higher rates is reshaping life insurers' economics. MetLife and Prudential stand to benefit a...
When the next earnings season looms, a single well-chosen tech stock can outshine a broad, aimless portfolio. Learn h...
Investors poured into bitcoin ETFs this week, reversing prior outflows as appetite for regulated crypto exposure retu...
As the world shifts toward cleaner power, investors face a choice: broad clean energy exposure or a focused nuclear a...
"Known Dada Remix Says" became a headline shorthand for a real case where seniors were targeted in a romance-and-inhe...
UnitedHealth Group just 52-week highs spark questions about sustainability. This guide breaks down what's driving the...